Andere Sprachen Cingulate Inc.

Aktien

A3E27L

US17248W2044

CING

Realtime-Estimate Cboe BZX Andere Börsenplätze 16:41:56 06.06.2024			% 5 Tage	% 1. Jan.
0,71 ^USD	-0,99 %		-2,38 %	-90,85 %

21.05.	FDA gibt Cingulate grünes Licht für die Einreichung eines Zulassungsantrags für CTx-1301 zur Behandlung von ADHS	CI
08.05.	Cingulate Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHD	21.05.
FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHD	21.05.
Cingulate Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	08.05.
Cingulate Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update	08.05.
Certain Pre-Funded Warrants of Cingulate Inc. are subject to a Lock-Up Agreement Ending on 7-MAY-2024.	07.05.
Certain Warrants of Cingulate Inc. are subject to a Lock-Up Agreement Ending on 7-MAY-2024.	07.05.
Certain Stock Options of Cingulate Inc. are subject to a Lock-Up Agreement Ending on 7-MAY-2024.	07.05.
Certain Common Stock of Cingulate Inc. are subject to a Lock-Up Agreement Ending on 7-MAY-2024.	07.05.
Peter J. Werth, Successful Pharma Entrepreneur, Philanthropist, Cingulate Investor and Board Member, to be Featured with Chairman and CEO Shane J. Schaffer on Benzinga All Live Access	30.04.
Cingulate to Participate in Planet MicroCap Showcase: Vegas 2024	16.04.
Cingulate Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01.04.
Cingulate Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	01.04.
Cingulate Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business Update	01.04.
Cingulate to Participate in Benzinga All Live Access Event	19.03.
Cingulate to Attend DCAT Week 2024 in New York City	06.03.
Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors	13.02.
Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to Its Board of Directors	13.02.
Cingulate Announces Closing of $7.5 Million Public Offering	06.02.
Top Midday Decliners	02.02.
Global markets live: Meta, Amazon, Apple, Tesla, Intel...	02.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Cingulate Inc.

Aktien

A3E27L

US17248W2044

CING

Andere Sprachen

Filter